Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 36 pages
Exam (elaborations)

NSG555/NSG 555 Exam 2 Nurse Practitioners in Primary Care II | Wilkes | 26/27 Updated (PDF)

Document preview thumbnail
Preview 4 out of 36 pages

INSTANT PDF DOWNLOAD — Verified NSG 555 Nurse Practitioners in Primary Care II Exam 2 | Wilkes University | 2026–2027 Updated (PDF) resource featuring actual exam questions, NGN‑style case studies, and complete rationales. Coverage includes advanced diagnostic reasoning, chronic disease management, preventive care, health promotion, patient safety, therapeutic communication, and evidence‑based practice in primary care settings. Emphasis on clinical decision‑making, prioritization of care, and integration of pathophysiology, pharmacology, and advanced assessment ensures exam readiness. Designed for guaranteed 100% correctness and alignment with Wilkes University curriculum, this study guide is ideal for students searching NSG 555 Exam 2 PDF, Primary Care II Study Guide, NSG 555 Test Bank, NSG 555 Verified Answers, NSG 555 Exam Prep 2026–2027, Nurse Practitioner Workbook, and NCLEX‑Style Primary Care Solutions.

Content preview

,NSG555/NSG 555 Exam 2 Nurse Practitioners in
1. A 68-year-old patient presents with sudden onset dyspnea, tachypnea, and pleuritic chest pain.
Oxygen saturation is 89% on room air. What is the priority nursing action?

A) Obtain a chest X-ray

B) Administer oxygen and notify the provider immediately

C) Draw a D-dimer

D) Prepare the patient for a V/Q scan

Correct Answer: Administer oxygen and notify the provider immediately

Rationale: Pulmonary embolism can cause rapid hypoxemia and hemodynamic collapse. The priority is
always to address life-threatening hypoxemia first. Oxygen administration improves tissue perfusion
while the provider is notified for definitive diagnosis and anticoagulation.



2. A patient is diagnosed with a massive pulmonary embolism and is hemodynamically unstable.
Which intervention is most appropriate?

A) Start thrombolytics immediately

B) Administer IV fluids aggressively

C) Provide immediate anticoagulation and hemodynamic support

D) Place an inferior vena cava filter

Correct Answer: Provide immediate anticoagulation and hemodynamic support

Rationale: Massive PE causes obstructive shock due to right ventricular failure. Immediate
anticoagulation (heparin) prevents further clot propagation, while hemodynamic support maintains
perfusion. Thrombolytics are reserved for massive PE with hemodynamic instability and no
contraindications.



3. A 72-year-old male complains of crushing substernal chest pain radiating to his left arm. His vital
signs are stable. What is the first priority intervention?

A) Administer aspirin and oxygen immediately

B) Obtain a 12-lead ECG

C) Draw troponin levels

D) Administer sublingual nitroglycerin

Correct Answer: Administer aspirin and oxygen immediately

,Rationale: In suspected acute MI, chewable aspirin (160–325 mg) and oxygen (if SpO2 < 90%) are
administered immediately. Aspirin reduces platelet aggregation and mortality. While ECG and
troponins are critical for diagnosis, they do not take precedence over interventions that limit
myocardial damage.



4. A patient with ST-elevation myocardial infarction is being prepared for emergent reperfusion.
Which statement best describes the treatment goal?

A) Pain control is the primary objective

B) Time is muscle; rapid restoration of blood flow is critical

C) Anticoagulation alone is sufficient

D) Fibrinolytics are preferred over PCI in all cases

Correct Answer: Time is muscle; rapid restoration of blood flow is critical

Rationale: In STEMI, rapid restoration of blood flow to the ischemic myocardium is the primary goal to
limit infarct size and reduce mortality. Primary PCI is preferred over fibrinolytics when available within
90 minutes.



5. According to the JNC 8 guidelines emphasized in NSG 555, what is the blood pressure target for a
65-year-old patient with no history of diabetes or chronic kidney disease?

A) <120/80 mmHg

B) <130/80 mmHg

C) <140/90 mmHg

D) <150/90 mmHg

Correct Answer: <150/90 mmHg

Rationale: JNC 8 explicitly states that for adults ≥60 years of age without diabetes or CKD, the
treatment target is <150/90 mmHg. (Note: ACC/AHA 2017 recommends <130/80, but Wilkes NSG 555
tests strictly on JNC 8).



6. What is the JNC 8 blood pressure target for a 45-year-old patient with a history of Type 2 Diabetes?

A) <130/80 mmHg

B) <140/90 mmHg

C) <150/90 mmHg

D) <120/80 mmHg

, Correct Answer: <140/90 mmHg

Rationale: JNC 8 recommends a blood pressure target of <140/90 mmHg for patients with diabetes or
chronic kidney disease, regardless of age. This is a key distinction from the ACC/AHA 2017 guidelines,
which recommend <130/80.



7. A 58-year-old patient with Type 2 Diabetes has an A1c of 8.5%. They are currently taking Metformin
1000 mg BID and have no contraindications to additional therapy. What is the most appropriate next
step in management?

A) Increase Metformin to 1500 mg BID

B) Add a Sulfonylurea

C) Add an SGLT-2 inhibitor

D) Start basal insulin

Correct Answer: Add an SGLT-2 inhibitor

Rationale: The patient is at goal maximum dose of metformin but has an A1c >7%. SGLT-2 inhibitors
are recommended as a second-line agent due to their proven cardiovascular and renal benefits,
independent of their glucose-lowering effects.



8. A 65-year-old patient with Type 2 Diabetes and an eGFR of 45 mL/min asks if they can continue
taking Metformin. What is your response?

A) Stop it immediately; it is strictly contraindicated

B) Continue it, but monitor closely; dose reduction may be needed

C) Double the dose to compensate for renal clearance

D) Switch to a sulfonylurea immediately

Correct Answer: Continue it, but monitor closely; dose reduction may be needed

Rationale: Metformin is contraindicated when eGFR is <30 mL/min. In Stage 3 CKD (eGFR 30-59), it can
be used cautiously, often requiring a dose reduction, with regular monitoring of renal function.



9. Which medication class has been shown to reduce major adverse cardiovascular events in patients
with type 2 diabetes and high cardiovascular risk, based on the LEADER trial?

A) DPP-4 inhibitors

B) SGLT-2 inhibitors

C) GLP-1 receptor agonists

Document information

Uploaded on
September 5, 2026
Number of pages
36
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$14.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
Lectben1
5.0
(3)
Sold
28
Followers
1
Items
830
Last sold
1 day ago




Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions